Alset Inc. (NASDAQ: AEI) has finalized a $1 million convertible loan agreement with DSS, including 17.8 million warrants, marking a strategic financial move in the materials sector.
Key Highlights
• Alset Inc. (NASDAQ: AEI) has entered into a $1 million convertible loan agreement with DSS Inc. As outlined in a new material agreement filed with the SEC.
• The deal includes the issuance of 17.8 million warrants, providing Alset with potential equity upside tied to DSS’s common stock.
• The agreement defines key terms, including a par value of $0.02 per share for DSS’s common stock, under Section 1.1 of the filing.
• The transaction is structured under a Securities Purchase Agreement dated June 23, 2026, with specific conditions for conversion and warrant exercise.
• Investors will monitor how the deal impacts Alset’s liquidity and strategic positioning in the materials sector.
Deal Terms Unveiled
Alset Inc. (NASDAQ: AEI) has executed a Securities Purchase Agreement with DSS Inc. Formalizing a $1 million convertible loan. The agreement, dated June 23, 2026, includes the issuance of 17.8 million warrants, which could significantly expand Alset’s equity exposure to DSS. The deal reflects a strategic move to bolster Alset’s financial flexibility while securing potential upside in DSS’s performance.
SEC Filing Details
The transaction was disclosed in a new material agreement exhibit filed with the U.S. Securities and Exchange Commission. The filing defines critical terms, such as the par value of DSS’s common stock at $0.02 per share, as outlined in Section 1.1. The agreement also specifies conditions for conversion, warrant exercise, and compliance with securities regulations, including Rule 144 under the Securities Act of 1933.
Financial Implications
The $1 million loan provides Alset with immediate capital, while the 17.8 million warrants offer long-term equity potential. The structure allows Alset to convert the loan into DSS shares at a predetermined rate, subject to adjustments for stock splits or dividends. This dual benefit could enhance Alset’s balance sheet while aligning its interests with DSS’s growth trajectory.
Regulatory Compliance
The agreement adheres to federal securities laws, including the Securities Exchange Act of 1934 and the Foreign Corrupt Practices Act of 1977. Key definitions, such as "Material Adverse Effect" and "Required Approvals," are explicitly tied to sections of the filing, ensuring clarity for investors and regulators. The deal also outlines procedures for removing restrictive legends from shares once compliance conditions are met.
Market Context
Alset’s move comes as the materials sector faces evolving demand dynamics and competitive pressures. The convertible loan structure is increasingly popular among growth-oriented firms seeking capital without immediate dilution. Analysts will watch how the deal positions Alset relative to peers, particularly if DSS’s stock performance triggers warrant exercises.
Competitive Landscape
The agreement underscores Alset’s efforts to strengthen its financial partnerships amid a challenging macroeconomic environment. Convertible loans are often favored for their flexibility, allowing companies to access capital while deferring equity dilution. This deal could set a precedent for similar transactions in the sector, particularly among firms with volatile stock prices.
Investor Insights
The $1 million convertible loan and 17.8 million warrants signal Alset’s confidence in DSS’s long-term potential. Investors should monitor DSS’s stock performance, as warrant exercises could impact Alset’s equity position. The deal also highlights Alset’s strategic approach to capital management, balancing immediate liquidity needs with future growth opportunities.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.
_11_18_2026_19_46_34_870440.jpg)





Please wait processing your request...